Pharma: Other News To Note
Monday, September 30, 2013
• Mylan Inc., of Pittsburgh, and Agila Specialities Global Pte. Ltd., of Bangalore, India, have had conditions on Mylan’s proposed acquisition of Agila imposed by the Federal Trade Commission (FTC), which is requiring the firms to divest 11 generic injectable drugs prior to the acquisition.
Outside of the US
Part of Thomson Reuters
Note: our contact information has changed
In the U.S. and Canada: +1-800-336-4474
Outside the U.S.: +44-203-684-1796
Hours: Monday - Friday, 8:00am - 6:00 pm EST
© 2017 Thomson Reuters. Reproduction, reposting content is strictly prohibited.